InsidersTradesSigma
HighTide Therapeutics, Inc. - B: insider trades · Hong Kong · HKEX
HKEX:hightide-therapeutics-inc-bHK·HKEXMcap 1.8Bn€Healthcare
Discover the full insider trade history of HighTide Therapeutics, Inc. - B, a publicly traded company based in Hong Kong. Shares are quoted on HK HK, under the authority of HKEX. Operating in the Healthcare sector, HighTide Therapeutics, Inc. - B has published 7 reports. Market capitalisation: €1.8bn. The latest transaction was filed on 8 May 2026 — Sale. Among the most active insiders: MA Lixiong. Every trade is openly available.
7
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
3 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
3.60 €
Analyst consensus
Income statement
Net income−232.1 M€0.0% margin
Valuation
P/Book5.2x
Beta-0.23
Balance sheet & cash
Market cap1.83 Bn€
Total debt126.9 M€
Free Cash Flow−167.0 M€
Debt / Equity35%
Profitability & ownership
ROE-58.8%
ROA-25.1%
% insiders55.8%
% institutions0.1%
Last declaration on 8 May 2026
Declarations0 total
No declarations found
0 of 0 declarations